Novavax (NVAX) Tops Q2 EPS by 210c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.05 --0%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of $0.58, $2.10 better than the analyst estimate of ($1.52). Revenue for the quarter came in at $424.43 million versus the consensus estimate of $237.39 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
